Secondary Logo

Journal Logo

Articles by Takenori Niioka, BS

Phase II Clinical Trial of Lenalidomide and Dexamethasone Therapy in Japanese Elderly Patients With Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide

Kobayashi, Takahiro; Miura, Masatomo; Niioka, Takenori; More

Therapeutic Drug Monitoring. 40(3):301-309, June 2018.

Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes

Niioka, Takenori; Fujishima, Naohito; Abumiya, Maiko; More

Therapeutic Drug Monitoring. 39(5):514-521, October 2017.

A Limited Sampling Model to Estimate Exposure to Lenalidomide in Multiple Myeloma Patients

Shida, Seiji; Takahashi, Naoto; Miura, Masatomo; More

Therapeutic Drug Monitoring. 36(4):505-509, August 2014.